Apoptosis is a novel approach to help people lose fat. Since research began several years ago on this activity of the compounds in Lipodrene®, Hi-Tech has been investigating many plant extracts and other natural substances for their ability to reduce adipose tissue mass by reducing the number of adipocytes through the mechanism of apoptosis. We have identified a number of agents that may induce apoptosis of adipose tissue, and found that some catecholamines and beta-adrenergic receptor agonists are prone to induce adipose tissue apoptosis when administered orally. These compounds include: clenbuterol, ractopamine, phenylethylamine, and alkaloids from acacia rigidula extract, including b-phenylethylamine, N-Methyl-b-phenylethylamine, and R-beta-methylphenylethylamine. These compounds appear to have the ability to increase the rate of apoptosis in adipose tissue cells, specifically white adipose tissue cells. It is suggested that Fastin’s active components demonstrate a wide array of action on adipocytes, including increased lipolysis, decreased Lipogenesis, decreased cell proliferation, and increased adipogenesis (blocking immature fat cells from maturing and storing lipids). In addition, Fastin assists in more effective lipid mobilization.

Fastin brings forth a trifecta of advancements in the fat loss arena: 1) a sophisticated manufacturing process that utilizes a dual delivery system technology for specific control of rapid and sustained release of its active compounds, 2) a proprietary active compound formulation that trumps the existing field of fat loss compounds and puts even ephedra in the back seat, 3) a novel approach to fat loss through triggering fat cell death (apoptosis).

Hi-Tech Pharmaceuticals recently launched Fastin™ into the weight loss arena. In recent months, Hi-Tech acquired rights to Fastin from King Pharmaceuticals. King Pharmaceuticals manufactured the brand name product Fastin (phentermine HCL) for Smith Kline Beecham. In December 1998, SK-Beecham withdrew Fastin from the market. Hi-Tech Pharmaceuticals has reformulated Fastin and expects it to be their top weight loss aid. Fastin is a pharmaceutical-grade dietary supplement indicated for weight loss in extremely overweight individuals. Fastin has booth immediate and delayed release profiles for appetite suppression, energy, and weight loss. Fastin is comprised of nine pharmaceutical-grade fat loss catalysts at precise ratios in order to achieve its extraordinary results. Fastin’s proprietary formula includes the following:

R-Beta-methylphenylethylamine HCL – this amazing compound is the active isomer of MPEA much like 1R, 25 Norephedrine was of PPA years ago. This compound stimulates norepinephrine unlike any other and leads to appetite suppression, energy, and ultimate fat loss.

Methylphenylethylamine tartrate – this is the racemic version of MPEA bound to tartaric acid, which keeps the molecule stable. This compound is found in Hi-Tech’s line and is a rising star of the fat loss industry.

Page 4 of 7 :: First | Last :: Prev | 1 2 3 4 5 6 7 | Next